Tag: Europe
-
Population Study Finds Genetic Links for Vertigo
A large-scale population genetics study finds several genetic variants associated with vertigo, a condition marked by dizziness and loss of balance.
-
AI-Designed Antibodies for Start-Up Sought in Open Call
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company.
-
European Life Science Venture Fund Raises €472M
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Foundation Plans $1B for Longevity Research
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years.
-
Trial Underway Testing Cancer Drug as Covid-19 Therapy
A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections.
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.
-
Pharma, Synthetic Bio Companies to Find Antibody Therapies
A pharmaceutical company and developer of synthetic genomic materials are collaborating on discovery of therapeutic antibodies to treat a range of diseases.